Vimian Group AB (publ) (VIMGF)

Akoya Biosciences Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.5	64.8	37.5	42.19	55.11	29.66
Cash & Short-Term Investments	67.5	64.8	37.5	42.19	55.11	29.66
Cash Growth	63.66%	72.80%	-11.13%	-23.44%	85.80%	146.31%
Accounts Receivable	58.9	55.2	46.1	41.17	30.96	22.31
Other Receivables	9.5	18	11.4	60.51	8.14	6.95
Receivables	68.4	73.2	57.5	101.68	39.1	29.26
Inventory	80	78.4	60.3	61.2	33	23.56
Prepaid Expenses	13.9	6.2	3.6	1.62	4.26	0.66
Other Current Assets	0.1	0.1	-	0	-	-0
Total Current Assets	229.9	222.7	158.9	206.69	131.47	83.15
Property, Plant & Equipment	45.2	46	35.6	34.85	26.41	16.77
Long-Term Investments	34	37.2	57.5	11.68	1.8	0.69
Goodwill	617.8	576.5	505.6	464.37	326.92	229.69
Other Intangible Assets	208.4	226.3	213.5	203.99	152.03	116.37
Long-Term Deferred Tax Assets	1.5	1	2.4	1.98	2.08	0.88
Other Long-Term Assets	0.1	0.1	0.2	-0	0	-
Total Assets	1,137	1,110	973.7	923.56	640.72	447.55
Accounts Payable	22.8	21.8	19.7	18.33	13.28	10.86
Accrued Expenses	21.1	17.4	10.6	20.97	13.67	7.02
Current Portion of Long-Term Debt	-	-	-	-	7.58	8.48
Current Portion of Leases	4.7	4.7	3.5	4.82	2.41	1.38
Current Income Taxes Payable	10.4	6.9	8.1	8.18	7.88	3.97
Current Unearned Revenue	-	0.7	5	0.38	0.29	0.07
Other Current Liabilities	35.2	58.4	28	113.58	27.59	36.95
Total Current Liabilities	94.2	109.9	74.9	166.26	72.69	68.74
Long-Term Debt	277.5	215.9	302	207.11	163.11	72.1
Long-Term Leases	11.8	13	8.3	9.03	7.27	3.95
Long-Term Deferred Tax Liabilities	27.4	29.4	27.4	24.41	17.49	15
Other Long-Term Liabilities	33.9	35.1	34.4	35.26	21.51	13.52
Total Liabilities	444.8	403.3	447	442.06	282.08	173.3
Common Stock	0.1	0.1	0.1	0.07	0.06	0
Additional Paid-In Capital	625.1	614.8	467.9	432.99	294.98	178.57
Retained Earnings	90.4	81.5	63.1	53.22	59.96	50.69
Comprehensive Income & Other	-32.7	3.5	-4.7	-4.46	2.41	-5.25
Total Common Equity	682.9	699.9	526.4	481.81	357.41	224.02
Minority Interest	9.2	6.6	0.3	-0.32	1.23	50.23
Shareholders' Equity	692.1	706.5	526.7	481.5	358.64	274.25
Total Liabilities & Equity	1,137	1,110	973.7	923.56	640.72	447.55
Total Debt	294	233.6	313.8	220.96	180.37	85.91
Net Cash (Debt)	-226.5	-168.8	-276.3	-178.76	-125.25	-56.24
Net Cash Per Share	-0.43	-0.33	-0.61	-0.44	-0.36	-0.19
Filing Date Shares Outstanding	526.62	523.89	522.42	441.12	389.32	0.03
Total Common Shares Outstanding	526.62	523.89	457.12	435.1	389.32	0.03
Working Capital	135.7	112.8	84	40.44	58.78	14.41
Book Value Per Share	1.30	1.34	1.15	1.11	0.92	8960.80
Tangible Book Value	-143.3	-102.9	-192.7	-186.55	-121.54	-122.04
Tangible Book Value Per Share	-0.27	-0.20	-0.42	-0.43	-0.31	-4881.60
Land	-	15.5	13	-	8.3	6.12
Machinery	-	28.3	17.6	-	11.51	5.94
Leasehold Improvements	-	7.8	4.7	-	0.92	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.